What is THREAD?
THREAD operates a decentralized research platform designed to facilitate studies for a global reach. The company provides a unique combination of clinical research technology and consulting services, enabling biopharma companies, contract research organizations (CROs), and study teams to design, manage, and scale next-generation research studies and electronic clinical outcome assessments (eCOA). THREAD's platform and scientific expertise aim to make studies more accessible, efficient, and patient-centric. The company has been recognized as a leader by Everest Group and IDC MarketScape for its contributions to decentralized clinical trials.
How much funding has THREAD raised?
THREAD has raised a total of $50M across 1 funding round:
Private Equity
$50M
Private Equity (2020): $50M with participation from JLL Partners and Water Street
Key Investors in THREAD
Water Street
Water Street Health Care Partners is a private equity firm established in 2005, specializing exclusively in the health care sector and headquartered in Chicago, Illinois.
JLL Partners
JLL Partners is a private equity firm that provides strategic investment and operational expertise to companies, often focusing on growth and transformation.
Undisclosed investor
Undisclosed investor participating in the funding round.
What's next for THREAD?
The recent major strategic investment signals a phase of accelerated growth and market expansion for THREAD. This capital infusion is likely to be directed towards enhancing its platform capabilities, broadening its service offerings, and strengthening its market presence within the rapidly evolving landscape of decentralized clinical trials. The company's focus on patient-centricity and operational efficiency positions it for continued leadership and innovation in the health tech sector.
See full THREAD company page
